Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Mar 17, 2018
    NAD Refers Insole Claims to FTC, FDA
  • Mar 16, 2018
    OPDP Moves Ahead with Adequate Provision Survey
  • Mar 14, 2018
    Heart Pump Manufacturer Agrees To Pay $3.1 Million To Resolve False Claims Allegations Concerning ‘Lavish’ Physician Meals
  • Mar 12, 2018
    Complete Lack of Risk Information Puzzles FDA
  • Mar 7, 2018
    APLB Issues First Untitled Letter in Three Years
  • Mar 7, 2018
    Oregon Governor Signs Bill Requiring Drug Manufacturer Cost Reporting
  • Mar 3, 2018
    Movement Seen on Communication Issues
  • Mar 3, 2018
    Bill To Eliminate Pharma Advertising Tax Deduction Introduced in Senate
  • Mar 1, 2018
    Justice Dept. To Join Case Against Opioid Makers
  • Feb 28, 2018
    FDA Targets Kratom on Several Fronts, Warns Against Products’ Use as Treatment for Opioid Use Disorder
  • More

Good Clinical Practice

  • Jul 12, 2018
    MINT Trial Protocol, Consent Changed After Public Citizen Raised Concerns
  • Jul 12, 2018
    ClinicalTrials.gov Adds FAQs on Voluntary Submissions
  • Jul 9, 2018
    OHRP Finds No Violations After Complaint Alleges Problems at UCSF Center
  • Jul 7, 2018
    House Appropriations Report Calls for Pilot Program To Improve Cancer Trials
  • Jul 7, 2018
    Appeals Panel Again Upholds Martoma Conviction
  • Jul 6, 2018
    More than Half of Industry Payments Reported to CMS in 2017 Were for Research
  • Jul 2, 2018
    Pa. Considers Cancer Trial Subject Reimbursement
  • Jul 1, 2018
    FDA Revises Antidepressant Drug Trial Design Guidance
  • Jun 26, 2018
    Michigan Medicine Reports Data Breach
  • Jun 26, 2018
    CDER Sends Untitled Letter To Israeli Company Over Missing PMR Study
  • More

U.S. Food Labeling

  • Aug 1,2013
    AMS Set To Eliminate Dual-Use Labeling Standard for Grades of Frozen Vegetables
  • Jul 25,2013
    Natural Products Trade Group Speaks Out Against Mandatory Labeling of GMO Foods
  • Jul 16,2013
    Natural Foods Group Backs Congressional Measures Mandating GMO Disclosure
  • Jul 15,2013
    FDA Examining Notification Requirements For Nutrient Content Claims on Supplements
  • Jul 11,2013
    Congresswomen Criticize FDA’s Menu Labeling Plans, Seek Multiple Exemptions in Final Rule
  • Jul 11,2013
    Meat Industry Sues USDA Over COOL Regulations, Seeks End to Labeling Disclosure for Muscle-cut Meats
  • Jul 9,2013
    FDA Eyeing Research on Consumer Reading of Labels
  • Jul 3,2013
    Conn. Governor Signs GMO Labeling Bill Into Law
  • Jun 14,2013
    Treasury Dept. Approves Voluntary Addition Of ‘Serving Facts’ Panel for Alcohol
  • Jun 14,2013
    FDA District Office Cites Ice Cream Manufacturer Over Labeling Omissions
  • More

FDA Regulation & Enforcement

  • Apr 20, 2021
    Study Finds Device Company Payments to Physicians Are Larger Than Drug Company Payments
  • Apr 15, 2021
    Appellate Court Will Not Enjoin Missouri Meat Labeling Law
  • Apr 15, 2021
    FDA Offers Plan To Reduce Amount of Heavy Metals in Baby Food
  • Apr 14, 2021
    FDA Withdraws Approvals of Five Generic Opioids After Sponsors Failed To Submit Annual Reports, REMS
  • Apr 9, 2021
    Texas Bills Would Allow Off-label Promotion
  • Apr 8, 2021
    Ninth Circuit Allows Fraud-on-the-FDA Claim in False Claims Act Suit Brought Against Medtronic
  • Apr 8, 2021
    Qui Tam Suit Alleging that Bristol-Myers Squibb Underpaid Medicaid Rebates Leads to $75 Million Settlement
  • Apr 1, 2021
    Legislation Introduced to Reduce Heavy Metals in Baby Food
  • Apr 1, 2021
    AMS Proposes Changes to Organic Substances List
  • Apr 1, 2021
    Court Sides With USDA in Suit Questioning Its Position on Hydroponics
  • More

Medical Devices

  • Apr 20, 2016
    House Bill Would Require Prior Written Notice to FDA for All Medical Device Design Changes
  • Apr 14, 2016
    FDA Updates Policy on Emergency Use Authorization for Medical Products In Light of New Authorities
  • Apr 14, 2016
    Court Dismisses False Claims Allegations, Finding No Fraud-Influenced Claims for Reimbursement
  • Apr 7, 2016
    Biomet Remains Under Investigation for Alleged ‘Improprieties’ Overseas as DPA Term Expires
  • Apr 6, 2016
    Interagency Online Tool Offers Compliance Guidance for Developers of Mobile Health Apps
  • Mar 31, 2016
    Citing ‘Ineffective’ Recall, FDA Calls for Halt in Use of Emergency Oxygen System
  • Mar 30, 2016
    Sleep Apnea Device Maker To Pay $34.8 Million To Resolve Whistleblower's Kickback Allegations
  • Mar 24, 2016
    Cardiovascular Systems Announces $8 Million Agreement To Settle False Claims Allegations
  • Mar 24, 2016
    Final Guidance on How To Make Testing for MRI-related Heating Manageable Is Released
  • Mar 17, 2016
    Increase in Number of Foreign Quality System Device Facility Inspections Continued in 2015
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.